Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions, with scientific support for its use as a medical treatment, researchers from the US Food and Drug Administration say in documents supporting its reclassification as a Schedule III substance.

Marijuana is currently classified as Schedule I, reserved for the most dangerous controlled substances, including heroin and LSD. In 2022, President Joe Biden asked US Health and Human Services Secretary Xavier Becerra and the attorney general to begin the administrative process of reviewing how marijuana is scheduled under federal law. HHS Assistant Secretary for Health Adm. Rachel Levine wrote a letter to the Drug Enforcement Administration in August in which she supported the reclassification to Schedule III, a list that includes “drugs with a moderate to low potential for physical and psychological dependence” such as ketamine, testosterone and Tylenol with codeine.

Rescheduling marijuana could open up more avenues for research, allow cannabis businesses to bank more freely and openly, and have firms no longer subject to a 40-year-old tax code that disallows credits and deductions from income generated by sales of Schedule I and II substances.

  • @[email protected]
    link
    fedilink
    66 months ago

    Alcohol would at worst be schedule 2 since it has medical use. It’s the cure to methanol poisoning and ethylene glycol poisoning.

    • @UrPartnerInCrime
      link
      26 months ago

      Damn dude, your comment made me look up the actual classes. For anyone else:

      Schedule 1: high chance of addiction and no professional use; weex, lsd, ecstacy, peyote

      Schedule 2: high potential for abuse, with use potentially leading to severe psychological or physical dependence. Considered dangerous; cocaine, methamphetamine, methadone, oxycodone, fentanyl, Dexedrine, Adderall

      Schedule 3: moderate to low potential for physical and psychological dependence; ketamine, anabolic steroids, testosterone

      Schedule 4: low potential for abuse and low risk of dependence; Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol

      Schedule 5: generally used for antidiarrheal, antitussive, and analgesic purposes; Lomotil, Motofen, Lyrica, Parepectolin